Arxius de News - Page 15 of 25 - Institut de Neurociències

June 17, 2020 In News By Laia Tremosa

The UB takes part in a study on the COVID-19 and lockdown psychological consequences in Spanish population

A research project on the psychological consequences of COVID-19 and the lockdown in Spain states that 78% of the population has observed an increase of feelings of uncertainty, while a 46% has felt their psychological discomfort grow. Led by the University of the Basque Country,...

June 4, 2020 In News By Laia Tremosa

Researchers find a new plasticity mechanism in neural connections

Neurons are able to detect the loss of autaptic synapsis -established by themselves- and recover the reduction of nervous neurotransmission through the formation and promotion of new connections. This is the main conclusion of the new article published in the journal Communications Biology, by researchers Artur Llobet...

May 28, 2020 In News By Laia Tremosa

Researchers identify two marine molecules with therapy potential against Alzheimer’s disease

An interdisciplinary research study of the UB identified two potential candidates to treat Alzheimer’s disease. These are two marine molecules, meridianine and lignarenone B, able to alter the activity of GSK3B activity, a protein associated with several neurodegenerative diseases. The researchers used several biocomputational techniques to...

May 22, 2020 In News By Laia Tremosa

Virtual reality to reduce stress and anxiety levels caused by the lockdown

Living the coronavirus situation means going through a global health emergency but also having to cope with extreme psychological stress which tests our identity and our relationships. A self-help virtual reality protocol called COVID Feel Good, in which the Institute of Neurosciences of the University of...

May 12, 2020 In News, Uncategorized By Laia Tremosa

first approach to gene therapy for MLC disease in preclinical models

A study involving the U750 CIBERER led by Raúl Estévez from the University of Barcelona-IDIBELL and IP of the Physiology And Pathology Of The Glia-Neurona Functional Relation group at the Institute of Neurosciences UB offers the first approach to gene therapy to treat the rare...

May 5, 2020 In News, Uncategorized By Laia Tremosa

Carme Uribe from the Institute of Neurosciences is awarded a MSCA Global Fellowship

Carme Uribe, who did her PhD at the CJNeuroLab, has been awarded a MSCA Global Fellowship that she will carry out at the Research Imaging Centre at the Centre for Addiction and Mental Health, Toronto under the supervision of Dr. Antonio Strafella and the Institute...

April 27, 2020 In News, Uncategorized By Laia Tremosa

A group of international researchers warns about the ethical dangers of ultrarealistic Virtual and Augmented Reality

Research on virtual reality started in the eighties, but it is now that good quality is available to the public and it can become a mass consumer product soon. However, there is almost no scientific knowledge on the effects of virtual reality in the long...

April 25, 2020 In News, Uncategorized By Laia Tremosa

Researchers use cell therapy to restore damaged brain areas in rats that suffered a stroke

Researchers from Lund University (Sweeden) and the Institute of Neurosciences of the University of Barcelona have restored, using cell therapy, the mobility and sensibility of rats that suffered a stroke. The results of this study were published in the journal Proceedings of the National Academy of...

April 20, 2020 In News, Uncategorized By Laia Tremosa

A team from the UB and IBUB describe an unknown route of assembly and ionic channel traffic in cardiac cells

Ionic channels -integral proteins in the cell membrane- are essential in several processes such as cardiac activity, nervous transmission, cell proliferation and the regulation of blood pressure. A study which has now been published in Science Advances describes for the first time the membrane traffic and association...

April 4, 2020 In News By Laia Tremosa

Researchers design a new family of molecules with high affinity to join altered receptors in neurodegenerative diseases

An article published in the Journal of Medicinal Chemistry shows a new family of molecules with high affinity to join imidazoline receptors, which are altered in the brain of those patients with neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington’s. According to the preclinical study, the merge...